PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE

by Ason, Brandon, van der Hoorn, José W. A., Chan, Joyce, Lee, Edward, Pieterman, Elsbet J., Nguyen, Kathy Khanh, Di, Mei, Shetterly, Susan, Tang, Jie, Yeh, Wen-Chen, Schwarz, Margrit, Jukema, J. Wouter, Scott, Rob, Wasserman, Scott M., Princen, Hans M. G., Jackson, Simon
Published in J Lipid Res (2014)